Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Critical Care Medicine
|
October 14, 2017
The authors reply
Esther Witteveen, Janneke Horn
Journal of Intensive Care Medicine
|
December 16, 2017
Causes of Mortality in ICU-Acquired Weakness
Linda van Wagenberg, Esther Witteveen, Luuk Wieske, et al.
Journal of Clinical Immunology
|
May 26, 2018
Treatment of Intracerebral Lesions with Abatacept in a CTLA4-Haploinsufficient Patient
Ester M van Leeuwen, Eloy Cuadrado, Anke M Gerrits, et al.
Journal of the Neurological Sciences
|
August 17, 2014
Muscle and nerve inflammation in intensive care unit-acquired weakness: a systematic translational review
Esther Witteveen, Luuk Wieske, Camiel Verhamme, et al.
Critical Care (London, England)
|
January 22, 2014
Neurofilaments as a plasma biomarker for ICU-acquired weakness: an observational pilot study
Luuk Wieske, Esther Witteveen, Axel Petzold, et al.
Intensive Care Medicine
|
March 11, 2015
Is gentamicin affecting the neuromuscular system of critically ill patients?
Luuk Wieske, Reinier M van Hest, Esther Witteveen, et al.
Annals of Translational Medicine
|
February 22, 2019
Muscle weakness in a <i>S. pneumoniae</i> sepsis mouse model
Esther Witteveen, Luuk Wieske, Emmy Manders, et al.
Annals of Translational Medicine
|
June 30, 2018
No association between systemic complement activation and intensive care unit-acquired weakness
Esther Witteveen, Luuk Wieske, Friso M de Beer, et al.
Muscle & Nerve
|
May 28, 2015
Assessment of intensive care unit-acquired weakness in young and old mice: An E. coli septic peritonitis model
Esther Witteveen, Inge C M Hoogland, Luuk Wieske, et al.
Annals of Intensive Care
|
April 7, 2017
Diagnostic accuracy of quantitative neuromuscular ultrasound for the diagnosis of intensive care unit-acquired weakness: a cross-sectional observational study
Esther Witteveen, Juultje Sommers, Luuk Wieske, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Critical Care Medicine
|
October 14, 2017
The authors reply
Esther Witteveen, Janneke Horn
Journal of Intensive Care Medicine
|
December 16, 2017
Causes of Mortality in ICU-Acquired Weakness
Linda van Wagenberg, Esther Witteveen, Luuk Wieske, et al.
Journal of Clinical Immunology
|
May 26, 2018
Treatment of Intracerebral Lesions with Abatacept in a CTLA4-Haploinsufficient Patient
Ester M van Leeuwen, Eloy Cuadrado, Anke M Gerrits, et al.
Journal of the Neurological Sciences
|
August 17, 2014
Muscle and nerve inflammation in intensive care unit-acquired weakness: a systematic translational review
Esther Witteveen, Luuk Wieske, Camiel Verhamme, et al.
Critical Care (London, England)
|
January 22, 2014
Neurofilaments as a plasma biomarker for ICU-acquired weakness: an observational pilot study
Luuk Wieske, Esther Witteveen, Axel Petzold, et al.
Intensive Care Medicine
|
March 11, 2015
Is gentamicin affecting the neuromuscular system of critically ill patients?
Luuk Wieske, Reinier M van Hest, Esther Witteveen, et al.
Annals of Translational Medicine
|
February 22, 2019
Muscle weakness in a <i>S. pneumoniae</i> sepsis mouse model
Esther Witteveen, Luuk Wieske, Emmy Manders, et al.
Annals of Translational Medicine
|
June 30, 2018
No association between systemic complement activation and intensive care unit-acquired weakness
Esther Witteveen, Luuk Wieske, Friso M de Beer, et al.
Muscle & Nerve
|
May 28, 2015
Assessment of intensive care unit-acquired weakness in young and old mice: An E. coli septic peritonitis model
Esther Witteveen, Inge C M Hoogland, Luuk Wieske, et al.
Annals of Intensive Care
|
April 7, 2017
Diagnostic accuracy of quantitative neuromuscular ultrasound for the diagnosis of intensive care unit-acquired weakness: a cross-sectional observational study
Esther Witteveen, Juultje Sommers, Luuk Wieske, et al.
Page
of 2